Pretreatment of Rho Kinase Inhibitor Inhibits Systemic Inflammation and Prevents Endotoxin-Induced Acute Lung Injury in Mice
Authors:
- 1 December 2011
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 171 (2) , e209-e214
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Rho kinase inhibition attenuates LPS-induced renal failure in mice in part by attenuation of NF-κB p65 signalingAmerican Journal of Physiology-Renal Physiology, 2009
- Activation of Rho Kinase Isoforms in Lung Endothelial Cells during InflammationThe Journal of Immunology, 2009
- Protective effect of fasudil, a Rho-kinase inhibitor, on chemokine expression, leukocyte recruitment, and hepatocellular apoptosis in septic liver injuryJournal of Leukocyte Biology, 2006
- Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injuryCardiovascular Research, 2004
- TLR signaling pathwaysSeminars in Immunology, 2004
- Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndromeThe Journal of Pathology, 2003
- Lipopolysaccharide Regulates Constitutive and Inducible Transcription Factor Activities Differentially in Vivo in the RatBiochemical and Biophysical Research Communications, 2001
- Multiple Signalling Pathways Lead to the Activation of the Nuclear Factor κB by the Rho Family of GTPasesJournal of Biological Chemistry, 1998
- Initiation of acute phase response and synthesis of cytokinesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1996
- Endotoxin-induced organ injuryCritical Care Medicine, 1993